Subscribe to Newsletter

Discovery & Development


Discovery & Development Dosage Forms

Psoriasis: More Than Skin Deep

| Rob Coker | 4 min read

Recent developments in the treatment of psoriasis has brought new hope to sufferers, and a surge in market standings.

Discovery & Development Clinical Trials

How Amgen Delivered a New Rare Disease Therapy

| 9 min read

We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.

Discovery & Development Drug Delivery

A Career of Antibody Drug Conjugates

| Stephanie Vine | 3 min read

From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.

Discovery & Development Translational Science

Shifting to Animal-Free Drug Development

| Tomasz Kostrzewski | 5 min read

The FDA says it wants to phase out mandatory animal testing requirements for drug approval. What comes next?

Discovery & Development Analytical Science

Understanding Mass Spectrometry for Biologics

| Chris Nortcliffe | 9 min read

As biologics become more complex, mass spec becomes more indispensable than ever in the drug developer’s toolbox.

Discovery & Development Drug Discovery

Eli Lilly and Purdue Expand Partnership with $250 Million Investment

| Rob Coker | 2 min read

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.

Discovery & Development Analytical Science

Cracking the Code of Phages and How They Can Fight TB

| Rob Coker | 2 min read

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.

Discovery & Development Analytical Science

Analysis and Characterization of GLP-1 Peptides

| Stephanie Vine | 10 min read

We ask an expert about best practices for working with these complicated therapies.

Discovery & Development Technology and Equipment

Appreciating Academic Spinouts

| Rob Coker | 3 min read

Let us not forget the important role of academic spinouts in innovating across the modalities.

Discovery & Development Drug Discovery

AI and Synthetic Pharmacokinetics

| Rob Coker | 3 min read

Researchers use AI to produce synthetic pharmacokinetic data.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker
OSZAR »